The inside story from Aspen on Covid-19 Dexamethasone: MUST LISTEN

Loading player...
This week, the world woke up to the exciting news that Dexamethasone, a cheap drug in the Aspen stable, dramatically improves the chances of survival for people seriously ill in hospitals with Covid-19. The Aspen share price has jumped up in value on the Johannesburg stock exchange as investors anticipate high demand for Dexamethasone. In this interview with BizNews founder Alec Hogg, Aspen group senior executive Stavros Nicolaou shares the details of what is known about Dexamethasone and how it will be made available. Learn more about your ad choices. Visit megaphone.fm/adchoices
17 Jun 2020 2PM English South Africa Investing · Business News

Other recent episodes

Jacques Broodryk: Trump hits SA officials with “bombshell” visa restrictions

In this interview with Chris Steyn, Jacques Broodryk, the Chief Spokesperson for Community Safety at AfriForum, hails the announcement by the Trump administration of visa restrictions for those “responsible for, or complicit in, the enactment or implementation of laws or policies that enable uncompensated land seizures, race-based discrimination, and/or the…
16 Sep 7AM 16 min